A Phase III, Randomized, Comparative, Open-label Study of Intravenous Iron Oligosaccharide (Monofer) Administered by Infusions or Repeated Bolus Injections in Comparison With Oral Iron Sulphate in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

Trial Profile

A Phase III, Randomized, Comparative, Open-label Study of Intravenous Iron Oligosaccharide (Monofer) Administered by Infusions or Repeated Bolus Injections in Comparison With Oral Iron Sulphate in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Iron isomaltoside 1000 (Primary) ; Ferrous sulfate
  • Indications Iron deficiency anaemia
  • Focus Registrational; Therapeutic Use
  • Acronyms PROCEED
  • Sponsors Pharmacosmos
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top